Highlights
- 1Scientific reports · 2022
- 2Journal of neuropathology and experimental neurology · 2025
Publications
54 publications
Funding
5 grants
Active
3 grants- Co-IR01CA308323-01A1Dual-[Hypoxia+Proliferation] PET as a Predictive Biomarker in Recurrent GlioblastomaNational Cancer Institute · 2026–2031
- Co-IR21CA289111-01A1Somatostatin Receptor 2 Expression in Pituitary Neuroendocrine Tumors as a Basis for PET/MRI guided Subtype Stratification and Radiotherapy PlanningNational Cancer Institute · 2025–2027
- Co-ICCRF 226613-01Development of novel preclinical models and therapeutics for ETMRChildren's Cancer Research Fund · 2023–2026
Completed grants (2)
- Co-IWRCG 223502-01State Selective Lethality: Exploiting a Previously Unrecognized Therapeutic Vulnerability in GlioblastomaWilliam Rhodes Center for Glioblastoma - Collaborative Research Initiative · 2022–2023
- Co-IWRCG 210432-01Machine Learning Approaches to Improve Histological Interpretation of GlioblastomaWilliam Rhodes Center for Glioblastoma - Collaborative Research Initiative · 2020–2021